Kamal Ramani Internal Medicine entered the industry of Internal Medicine Doctors in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact Kamal Ramani by calling (212) 661-0570 during business hours. You can also write to the business’ Single Location at 235 East 40th St Apartment 20d, New York City, New York NY 10016. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Kamal Ramani Internal Medicine |
Representative: | Kamal Ramani |
Place of Business: | 235 East 40th St Apartment 20d, New York City, NY 10016 |
Contact Number: | (212) 661-0570 |
Type of Service: | Internal Medicine Doctors |
SIC Number: | 8011 |
NAICS Number: | 621111 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2008 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Kamal Ramani Internal Medicine is a company operating from New York, New York providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2008 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 621111 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Kamal Ramani Internal Medicine has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Kamal Ramani at (212) 661-0570 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 235 East 40th St Apartment 20d in New York City, New York 10016 and can be engaged online through the company website at , the company Twitter , and Facebook page .